IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus

Young Mok Lee, Nobuaki Miyahara, Katsuyuki Takeda, John Prpich, Anita Oh, Annette Balhorn, Anthony Joetham, Erwin W. Gelfand, Azzeddine Dakhama

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN-γ production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown. Objectives: To define the role of IFN-γ in the development of RSV-mediated airway hyperresponsiveness (AHR) and lung histopathology in mice. Methods: Wild-type (WT) and IFN-γ knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection. Measurements and Main Results: Both WT and IFN-γ knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN-γ knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN-γ during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN-γ knockout mice. Adoptive transfer of WT T cells into IFN-γ knockout mice before primary infection restored IFN-γ production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN-γ during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection. Conclusions: IFN-γ production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN-γ during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.

Original languageEnglish
Pages (from-to)208-218
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume177
Issue number2
DOIs
Publication statusPublished - Jan 15 2008
Externally publishedYes

Fingerprint

Respiratory Syncytial Viruses
Knockout Mice
Infection
Eosinophilia
Mucus
Lung
Respiratory Syncytial Virus Infections
Intranasal Administration
Bronchiolitis
Adoptive Transfer
Weaning
Coinfection
Cytokines
Inflammation
T-Lymphocytes
Therapeutics

Keywords

  • Airway hyperresponsiveness
  • Asthma
  • Interferon-γ
  • Mice
  • Respiratory syncytial virus

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus. / Lee, Young Mok; Miyahara, Nobuaki; Takeda, Katsuyuki; Prpich, John; Oh, Anita; Balhorn, Annette; Joetham, Anthony; Gelfand, Erwin W.; Dakhama, Azzeddine.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 177, No. 2, 15.01.2008, p. 208-218.

Research output: Contribution to journalArticle

Lee, Young Mok ; Miyahara, Nobuaki ; Takeda, Katsuyuki ; Prpich, John ; Oh, Anita ; Balhorn, Annette ; Joetham, Anthony ; Gelfand, Erwin W. ; Dakhama, Azzeddine. / IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus. In: American Journal of Respiratory and Critical Care Medicine. 2008 ; Vol. 177, No. 2. pp. 208-218.
@article{a581a694d2114fcdbc1fa8c5cea2d4c1,
title = "IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus",
abstract = "Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN-γ production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown. Objectives: To define the role of IFN-γ in the development of RSV-mediated airway hyperresponsiveness (AHR) and lung histopathology in mice. Methods: Wild-type (WT) and IFN-γ knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection. Measurements and Main Results: Both WT and IFN-γ knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN-γ knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN-γ during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN-γ knockout mice. Adoptive transfer of WT T cells into IFN-γ knockout mice before primary infection restored IFN-γ production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN-γ during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection. Conclusions: IFN-γ production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN-γ during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.",
keywords = "Airway hyperresponsiveness, Asthma, Interferon-γ, Mice, Respiratory syncytial virus",
author = "Lee, {Young Mok} and Nobuaki Miyahara and Katsuyuki Takeda and John Prpich and Anita Oh and Annette Balhorn and Anthony Joetham and Gelfand, {Erwin W.} and Azzeddine Dakhama",
year = "2008",
month = "1",
day = "15",
doi = "10.1164/rccm.200612-1890OC",
language = "English",
volume = "177",
pages = "208--218",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus

AU - Lee, Young Mok

AU - Miyahara, Nobuaki

AU - Takeda, Katsuyuki

AU - Prpich, John

AU - Oh, Anita

AU - Balhorn, Annette

AU - Joetham, Anthony

AU - Gelfand, Erwin W.

AU - Dakhama, Azzeddine

PY - 2008/1/15

Y1 - 2008/1/15

N2 - Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN-γ production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown. Objectives: To define the role of IFN-γ in the development of RSV-mediated airway hyperresponsiveness (AHR) and lung histopathology in mice. Methods: Wild-type (WT) and IFN-γ knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection. Measurements and Main Results: Both WT and IFN-γ knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN-γ knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN-γ during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN-γ knockout mice. Adoptive transfer of WT T cells into IFN-γ knockout mice before primary infection restored IFN-γ production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN-γ during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection. Conclusions: IFN-γ production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN-γ during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.

AB - Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN-γ production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown. Objectives: To define the role of IFN-γ in the development of RSV-mediated airway hyperresponsiveness (AHR) and lung histopathology in mice. Methods: Wild-type (WT) and IFN-γ knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection. Measurements and Main Results: Both WT and IFN-γ knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN-γ knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN-γ during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN-γ knockout mice. Adoptive transfer of WT T cells into IFN-γ knockout mice before primary infection restored IFN-γ production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN-γ during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection. Conclusions: IFN-γ production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN-γ during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.

KW - Airway hyperresponsiveness

KW - Asthma

KW - Interferon-γ

KW - Mice

KW - Respiratory syncytial virus

UR - http://www.scopus.com/inward/record.url?scp=38349080997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349080997&partnerID=8YFLogxK

U2 - 10.1164/rccm.200612-1890OC

DO - 10.1164/rccm.200612-1890OC

M3 - Article

C2 - 17962634

AN - SCOPUS:38349080997

VL - 177

SP - 208

EP - 218

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -